Regeneron Pharmaceuticals (Eylea) | About the Brand



Regeneron is a company based in New York USA. It is a biotechnology company founded back in 1988, and was originally focused on neurotrophic factors, and the regenerative capabilities they possess. They later on branched out into the study of both tyrosine kinase and cytokine receptors, and they have developed afibercept, which is a VEGF inhibitor. VEGF is a protein that stimulates the growth of blood vessels, and is sometimes needs to be blocked in order to treat some ailments.  

One of those ailments includes the growth of abnormal blood vessels in the eye, which can then discharge leakages, leading to loss of vision. Afibercept, with the brand name Eylea, is made specifically for patients who have diseases related to this like wet AMD, as well as DME and MEfRVO. Eylea is the #1 prescribed treatment in its class according to the IBM Truven MarketScan Data from !4 of 2018 to Q3 of 2019, and has helped millions of patients stave off the debilitating effects of retinal diseases. 


Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.